N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2)
   Google Scholar   
Citation:
J Clin Oncol vol 30 (15 suppl) abstr 7555
Meeting Instance:
ASCO 2012
Year:
2012
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2071  
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Networks:
 
Study
NCCTG-N0821
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: